story of the week
MRD Dynamics During Ixazomib Maintenance for Improved Prognostication of Patients With Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials
Blood 2022 Sep 21;[EPub Ahead of Print], B Paiva, I Manrique, MA Dimopoulos, F Gay, CK Min, S Zweegman, I Spicka, R Teipel, MV Mateos, N Giuliani, M Cavo, C Rojas, W Fu, K Suryanarayan, A Vorog, C Li, B Wang, J Estevam, R Labotka, AB DashFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.